These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 9457095)

  • 1. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.
    Race EM; Adelson-Mitty J; Kriegel GR; Barlam TF; Reimann KA; Letvin NL; Japour AJ
    Lancet; 1998 Jan; 351(9098):252-5. PubMed ID: 9457095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in T-lymphocyte count after initiation of highly active antiretroviral therapy in HIV-infected patients with history of Mycobacterium avium complex infection.
    Lazaro E; Coureau G; Guedj J; Blanco P; Pellegrin I; Commenges D; Dabis F; Moreau JF; Pellegrin JL; Thiébaut R;
    Antivir Ther; 2006; 11(3):343-50. PubMed ID: 16759051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Focal mycobacterial lymphadenitis after starting highly active antiretroviral therapy].
    Schwietert M; Battegay M
    Dtsch Med Wochenschr; 1999 Jan; 124(3):45-8. PubMed ID: 9987485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency.
    Girmenia C; Martino P; Mazzucconi MG; Bizzoni L; Cassone A
    Haemophilia; 2000 Mar; 6(2):116-7. PubMed ID: 10781200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up.
    Phillips P; Bonner S; Gataric N; Bai T; Wilcox P; Hogg R; O'Shaughnessy M; Montaner J
    Clin Infect Dis; 2005 Nov; 41(10):1483-97. PubMed ID: 16231262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritonitis due to Mycobacterium avium complex in patients with AIDS: report of five cases and review of the literature.
    Wu UI; Chen MY; Hu RH; Hsieh SM; Sheng WH; Lo YC; Hung CC; Chang SC
    Int J Infect Dis; 2009 Mar; 13(2):285-90. PubMed ID: 18955006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.
    Hammer SM; Squires KE; Hughes MD; Grimes JM; Demeter LM; Currier JS; Eron JJ; Feinberg JE; Balfour HH; Deyton LR; Chodakewitz JA; Fischl MA
    N Engl J Med; 1997 Sep; 337(11):725-33. PubMed ID: 9287227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
    Karakousis PC; Moore RD; Chaisson RE
    Lancet Infect Dis; 2004 Sep; 4(9):557-65. PubMed ID: 15336223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of tuberculosis or Mycobacterium avium-intracellulare complex infection in HIV-infected patients].
    Shirasaka T
    Kekkaku; 2007 Nov; 82(11):845-8. PubMed ID: 18078110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disseminated Mycobacterium avium infection among HIV-infected patients in Kenya.
    Gilks CF; Brindle RJ; Mwachari C; Batchelor B; Bwayo J; Kimari J; Arbeit RD; von Reyn CF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):195-8. PubMed ID: 7834402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?
    Lange CG; Woolley IJ; Brodt RH
    Drugs; 2004; 64(7):679-92. PubMed ID: 15025543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly active antiretroviral therapy.
    Di Perri G; Bonora S; Vento S; Allegranzi B; Concia E
    Lancet; 1998 Apr; 351(9108):1056; author reply 1058-9. PubMed ID: 9546529
    [No Abstract]   [Full Text] [Related]  

  • 13. Sources of disseminated Mycobacterium avium infection in AIDS.
    von Reyn CF; Arbeit RD; Horsburgh CR; Ristola MA; Waddell RD; Tvaroha SM; Samore M; Hirschhorn LR; Lumio J; Lein AD; Grove MR; Tosteson AN
    J Infect; 2002 Apr; 44(3):166-70. PubMed ID: 12099743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
    French M; Keane N; McKinnon E; Phung S; Price P
    HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of discontinuing maintenance therapy in human immunodeficiency virus-infected subjects with disseminated Mycobacterium avium complex: AIDS Clinical Trial Group 393 Study Team.
    Aberg JA; Williams PL; Liu T; Lederman HM; Hafner R; Torriani FJ; Lennox JL; Dube MP; MacGregor RR; Currier JS;
    J Infect Dis; 2003 Apr; 187(7):1046-52. PubMed ID: 12660918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of secondary prophylaxis against disseminated Mycobacterium avium complex infection and toxoplasmic encephalitis.
    Zeller V; Truffot C; Agher R; Bossi P; Tubiana R; Caumes E; Jouan M; Bricaire F; Katlama C
    Clin Infect Dis; 2002 Mar; 34(5):662-7. PubMed ID: 11810599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathological and Microbiological Profile of Tuberculous Lymphadenitis in HIV-Infected Patients with Special Emphasis on Its Corroboration with CD4+ T-Cell Counts.
    Mondal K; Mandal R
    Acta Cytol; 2015; 59(2):156-62. PubMed ID: 25896853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of disseminated Mycobacterium avium-complex infection in HIV patients receiving antiretroviral therapy with use of Mycobacterium avium-complex prophylaxis.
    Jung Y; Song KH; Choe PG; Park WB; Bang JH; Kim ES; Kim HB; Park SW; Kim NJ; Oh MD
    Int J STD AIDS; 2017 Dec; 28(14):1426-1432. PubMed ID: 28592210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.
    MacGregor RR; Hafner R; Wu JW; Murphy RL; Perlman DC; Bermudez LE; Inderlied CB; Picker LJ; Wallis RS; Andersen JW; Mahon LF; Koletar SL; Peterson DM;
    AIDS Res Hum Retroviruses; 2005 Aug; 21(8):689-95. PubMed ID: 16131307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
    Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.